|
Volumn 30, Issue 2, 2002, Pages 103-107
|
Clinical utility of ABCL (Agalicus Mushroom Extract) treatment for C-type hepatitis
a a |
Author keywords
glucan; GTP; Agaricus mushroom; C type hepatitis; Clinical evaluation
|
Indexed keywords
AGARICUS BLAZEI EXTRACT;
BETA GLUCAN;
GAMMA GLUTAMYLTRANSFERASE;
PLANT EXTRACT;
POLYSACCHARIDE;
UNCLASSIFIED DRUG;
AGARICUS BLAZEI;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CYTOKINE RELEASE;
DISEASE SEVERITY;
DRUG FORMULATION;
DRUG INDUCED DISEASE;
ENZYME ACTIVITY;
FEMALE;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
LYMPHOCYTE;
MACROPHAGE;
MALE;
MUSHROOM;
TOXICITY;
|
EID: 0036033883
PISSN: 03863603
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (9)
|